BrainsWay (BWAY) Q2 2025 Earnings Call August 13, 2025 08:00 AM ET Speaker0Day, and welcome to the Brainsway Second Quarter twenty twenty five Earnings Conference Call. All participants will be in listen only mode. Please note this event is being recorded. I would now like to turn the conference over to Garth Russell with Investor Relations from LifeSci Advisors. Please go ahead.Speaker1Thank you all, and welcome to Brainsway's second quarter twenty twenty five earnings conference call. With us today are Br ...

Core Insights - Beauty Health reported a significant turnaround in profitability for Q2 FY2025, with net income (GAAP) increasing to $19.7 million from $0.2 million a year earlier, and GAAP revenue of $78.2 million exceeding analyst estimates of $74.54 million [1][5][12] - The company raised its full-year guidance, attributing gains to cost control and an improved product mix, despite a year-over-year decline in delivery system sales [1][12] Financial Performance - Q2 2025 GAAP EPS was $0.03, compared to an estimate of $(0.05) and $(0.10) in Q2 2024, reflecting a year-over-year improvement of $0.13 [2] - Revenue for Q2 2025 was $78.2 million, down 13.7% from $90.6 million in Q2 2024, primarily due to a 43.5% drop in delivery system sales [2][6] - Gross margin improved to 62.8%, up 17.6 percentage points from 45.2% in the previous year, driven by higher consumable sales [2][8] - Adjusted EBITDA reached $13.9 million, a significant recovery from a loss of $(5.2) million in the previous year [2][5] Business Model and Strategy - Beauty Health focuses on developing and selling skin health devices, with its flagship product being the Hydrafacial delivery system, complemented by consumable products [3][10] - The company aims to build a recurring revenue stream, with over 70% of revenue derived from consumables tied to treatments [4][6] - Recent strategic initiatives include launching innovative product add-ons and enhancing relationships with skincare providers [4][11] Market Dynamics - The company shifted to a distributor-based sales model in China, which may reduce operational complexity but could also impact direct control [7] - Sales in the Asia-Pacific region fell 43.4% year-over-year, while EMEA sales saw a moderate decline, indicating challenges in various markets [7] - Despite the decline in equipment sales, consumable sales remained stable across regions, highlighting the importance of recurring revenue [7] Future Outlook - Management raised its guidance for net sales to between $285 million and $300 million, with adjusted EBITDA expectations moving to $27 million to $35 million [12] - The sales outlook for Q3 2025 is projected to be between $65 million and $70 million, assuming no significant market disruptions [12]

Financial Data and Key Metrics Changes - Net revenue for Q2 2025 was $28.5 million, a 41% increase from $20.3 million in Q2 2024, driven by the launch of the compact launcher and increased sales [5][6] - Gross profit for Q2 2025 was $17.6 million, representing 62% of net revenue, consistent with the previous year [6] - Net income for Q2 2025 was $2.4 million, up from $2.1 million in Q2 2024, attributed to increased product sales [7] - Adjusted EBITDA for Q2 2025 totaled $4.3 million, compared to $2.8 million in Q2 2024 [7][8] - Cash and cash equivalents decreased to $13 million from $25.7 million at the end of November 2024, reflecting planned inventory increases [8] Business Line Data and Key Metrics Changes - Direct-to-consumer revenues increased by $2.2 million through verna.com and amazon.com compared to the prior year [6] - Sales to dealers increased by $3.9 million or 106%, largely due to initial stocking orders for Sportsman's Warehouse [6][11] Market Data and Key Metrics Changes - International sales reached $2.6 million, an 86% increase from the prior year, including a one-time bump in royalties from partners [19] - The company is expanding its presence in new markets, including farming and ranching, with new chains testing Berna products [15] Company Strategy and Development Direction - The company plans to introduce Burna Care, a recurring revenue model for replacing lost or damaged launchers [23][66] - The strategy includes expanding the number of stores carrying Berna products and increasing the range of products offered [15][29] - The company is focusing on enhancing its marketing efforts, including partnerships with celebrity influencers [21][22] Management's Comments on Operating Environment and Future Outlook - Management noted a slowdown in consumer spending but expects continued growth due to increased distribution and brand awareness [9][29] - The company anticipates a growth rate of 25% to 40% for the year, despite market softness [35][36] - Management is optimistic about the performance of company-owned stores, which are already profitable [17][72] Other Important Information - The compact launcher has better margins and is expected to drive sales growth [28] - The company is shifting to a more efficient assembly pod-based manufacturing system to improve production [29] Q&A Session Summary Question: June trends and growth expectations - Management observed a 40% sales increase during civil unrest in June, but noted it was a transitory trend [34][35] Question: Softness in the market - Management indicated signs of softness, including higher abandoned cart rates and consumer price sensitivity [38][39] Question: Expansion with Sportsman's Warehouse - Management clarified that there are currently 22 store-within-a-store locations, with plans to increase to 33 [41][42] Question: Channel mix evolution - Management expects brick-and-mortar sales to grow faster than online, with Amazon outpacing Berna.com [49][51] Question: Recurring revenue model - The Burna Care program will function like an insurance policy, offering coverage for lost or damaged launchers [63][66] Question: Performance of Scottsdale store - The Scottsdale store's success is attributed to its prime location and strong sales personnel [72][74]

Financial Data and Key Metrics Changes - Net revenue for Q2 2025 was $28.5 million, a 41% increase from $20.3 million in Q2 2024, driven by the launch of the compact launcher and increased sales [5][6] - Gross profit for Q2 2025 was $17.6 million, maintaining a gross margin of 62%, compared to $12.6 million and 62% in Q2 2024 [6] - Net income for Q2 2025 was $2.4 million, up from $2.1 million in Q2 2024, attributed to increased product sales [7][8] - Adjusted EBITDA for Q2 2025 totaled $4.3 million, compared to $2.8 million in Q2 2024 [8] - Cash and cash equivalents decreased to $13 million from $25.7 million at the end of Q4 2024, reflecting planned inventory increases [9] Business Line Data and Key Metrics Changes - Direct-to-consumer revenues increased by $2.2 million through verna.com and amazon.com compared to the prior year [6] - Sales to dealers increased by $3.9 million or 106%, largely due to initial stocking orders for Sportsman's Warehouse [6][12] Market Data and Key Metrics Changes - International sales reached $2.6 million, an 86% increase from the prior year, including a one-time bump in royalties from partners [19] - The company is expanding its presence in new markets, including farming and ranching, with new chains testing Berna products [16] Company Strategy and Development Direction - The company plans to introduce Burnet Care, a recurring revenue model for replacing lost or damaged launchers [23] - The strategy includes expanding the number of stores carrying Berna products and increasing the range of products offered [17][30] - The company is focusing on enhancing its marketing efforts, including partnerships with celebrity influencers [21][22] Management's Comments on Operating Environment and Future Outlook - Management noted a slowdown in consumer spending but expects continued growth due to increased distribution channels and product normalization [10][30] - The company anticipates a growth rate of 25% to 40% for the year, despite some market softness [36][37] Other Important Information - The compact launcher has better margins and is expected to drive sales growth, with production adjusted to meet demand [28][29] - The company is shifting to a more efficient assembly pod-based manufacturing system to improve quality and reduce labor requirements [29][30] Q&A Session Summary Question: June trends and growth expectations - Management observed a 40% sales increase during civil unrest in June but noted it was a transitory trend, with a sustained growth expectation of 25% to 40% for the year [34][36] Question: Softness in the market - Management indicated signs of softness, including higher abandoned cart rates and sticker shock at checkout, but expects significant growth despite seasonal slowdowns [40][41] Question: Expansion with Sportsman's Warehouse - Management clarified that there are currently 22 store-within-a-store locations, with plans to increase to 33, and noted that some point-of-sale locations are outperforming shooting pods [42][45] Question: Channel mix evolution - Management expects brick-and-mortar sales to grow faster than online sales, with Amazon continuing to outpace Berna's direct sales [51][54] Question: Recurring revenue model - The upcoming Burnet Care will function like an insurance policy, allowing customers to pay a monthly fee for coverage on their launchers [65][66] Question: Performance of Scottsdale store - The Scottsdale store's success is attributed to its prime location, high traffic, and effective sales personnel, indicating a strong market fit [74][76]

Core Insights - OptimizeRx Corp. has appointed Steve Silvestro, the current CEO, to its Board of Directors effective June 20, 2025, enhancing leadership and execution of value creation plans [1][2][3] Company Leadership - Steve Silvestro joined OptimizeRx in 2019, became CEO in March 2025, and previously served as interim CEO from January 2025 [2][4] - The Board of Directors has recognized Silvestro's leadership and the progress made under his tenure, which has strengthened the company's position and laid a foundation for long-term shareholder value [3] Strategic Direction - Silvestro expressed optimism about OptimizeRx's direction, emphasizing a focus on operational excellence, customer satisfaction, and a strong outlook for 2025 and beyond [3] - The company aims to deepen its value proposition with pharmaceutical partners, accelerate the shift towards a recurring revenue model, and progress towards achieving Rule of 40 performance [3][4] Company Overview - OptimizeRx is a healthcare technology company that connects life science brands with patients and healthcare providers through innovative AI-driven tools [5][6] - The company is committed to privacy-safe, patient-centric technology, partnering with leading pharmaceutical and life sciences companies to transform healthcare [6]

Core Insights - Flotek Industries (FTK) has achieved a 52-week high of $16.83, reflecting a remarkable 200% increase over the past year, driven by investor confidence in its transformation strategy focused on recurring revenues, analytics expansion, and global growth [1][8] - The company is set to join the Russell 3000 Index, which is expected to enhance its visibility and attract institutional interest [10] Strategic Developments - Flotek's strategic acquisition of power optimization assets from ProFrac Holding Corp. for $108 million is a significant catalyst for growth, transitioning the company into a recurring-revenue, data-focused business model [3] - The acquisition is projected to generate $14 million in EBITDA for 2025 and $20 million for 2026, with 22 units already leased to ProFrac [3][8] Revenue Growth and Market Position - The Data Analytics Services (DAS) segment is becoming more predictable, supported by a $20 million annual take-or-pay chemistry contract with ProFrac, providing long-term revenue visibility [4] - International chemistry revenues surged nearly 250% year-over-year in Q1 2025, with strong growth in the Middle East and Argentina, positioning FTK to diversify its customer base [5][9] Financial Performance - In Q1 2025, Flotek reported a 37% year-over-year revenue growth, a 41% increase in gross profit, and a 244% surge in net income, with adjusted EBITDA nearly doubling [9] - Management anticipates an 80% year-over-year growth in adjusted EBITDA for 2025, driven by operating leverage from analytics assets and international expansion [10] Competitive Advantage - Flotek's hybrid model, which combines proprietary hardware with analytics and long-term leases, offers more predictability and margin resilience compared to competitors like ChampionX, which relies on one-time product sales [11][12] - The DAS segment is expected to generate more revenue in 2025 than in all of 2024, highlighting the effectiveness of the expanded partnership with ProFrac [12] Valuation and Growth Outlook - Flotek's forward price-to-earnings ratio stands at 25.71, higher than the subindustry average of 12.62, reflecting justified premium due to its growth potential [13] - The Zacks Consensus Estimate projects earnings growth of 56% in 2025 and 27% in 2026, indicating a strong growth profile in the energy services sector [15] Conclusion - Flotek's stock price surge is attributed to its successful execution across multiple fronts, including the ProFrac deal, international expansion, and a shift towards a high-margin, recurring-revenue model [18] - The company is currently rated as a Strong Buy, with upward estimate revisions and margin expansion providing a solid investment thesis [19]

Core Insights - Comstock Holding Companies, Inc. (CHCI) shares have decreased by 17.4% since the earnings report for Q1 2025, contrasting with a 4.1% increase in the S&P 500 index during the same period [1] - The company reported earnings per share of 15 cents, up from 9 cents year-over-year, with revenues of $12.6 million, a 19% increase from $10.6 million in the prior-year quarter [2] - Net income rose by 75% to $1.6 million compared to $0.9 million in the previous year, while adjusted EBITDA grew by 38% to $2.1 million [3] Financial Performance - Comstock's managed portfolio increased to 76 assets from 65 a year ago, with a 93% leased rate in commercial properties and a 96% leased rate in residential properties [4] - ParkX, the parking management subsidiary, achieved a 56% revenue increase, significantly contributing to the overall financial performance [5] - The company maintained stable operating costs, with selling, general, and administrative expenses flat at $0.5 million compared to the previous year [7] Strategic Outlook - The CEO emphasized that Q1 results align with long-term strategic goals, marking the 25th consecutive quarter of revenue growth [6] - Strong leasing momentum was noted, with new tenants and high occupancy rates in premium residential properties [6] - Expansion efforts are focused on the construction of The Row at Reston Station, which is expected to be a transformative project for the company [8]